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Exposure tomanganese (Mn) is associatedwith neurobehavioral effects. There is disagreement onwhether
commonly occurring exposures in welding, ferroalloy, and other industrial processes produce neurologi-
cally signiﬁcant neurobehavioral changes representing parkinsonism. A reviewofmethodological issues in
the human epidemiological literature onMn identiﬁed: (1) studies focused on idiopathic Parkinson disease
without consideringmanganism, a parkinsonian syndrome; (2) studieswith healthyworker effect bias; (3)
studies with problematic statistical modeling; and (4) studies arising from case series derived from liti-
gation. Investigations with adequate study design and exposure assessment revealed consistent neuro-
behavioral effects and attributable subclinical and clinical signs and symptoms of impairment. Twenty-
eight studies showan exposure-response relationship betweenMn and neurobehavioral effects, including
11with continuous exposuremetrics and sixwith three or four levels of contrasted exposure. The effects of
sustained low-concentration exposures to Mn are consistent with the manifestations of early manganism,
i.e., consistentwith parkinsonism. This is compelling evidence thatMn is a neurotoxic chemical and there is
good evidence that Mn exposures far below the current US standard of 5.0 mg/m3 are causing impairment.
 2013, Occupational Safety and Health Research Institute. Published by Elsevier. All rights reserved.1. Introduction
Although the manganese (Mn) literature provides a relatively
consistent body of evidence, there are inconsistencies and concerns
that bear exploration. One concern is the signiﬁcance of early
neuropsychological effects and subtle impairment. Another is
whether these effects are manifestations of parkinsonism. Other
areas of contention include aspects of study design, analysis, bias,
and inference. This review focuses on the literature reﬂecting these
concerns and then summarizes current ﬁndings.
2. Neurological effects
2.1. Neuropsychological testing
Neuropsychological examinations can identify subtle and sub-
clinical effects such as memory loss or increased anxiety [1,2].pational Safety and Health, Risk Ev
se of the author and do not necessa
erms of the Creative Commons At
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l Safety and Health Research InstitNeurobehavioral testing began in the early 1960s based on exper-
imental and clinical psychology and neuropsychology, and was
used to identify developing impairment and prevent further dete-
rioration [3]. Tests encompassing diverse neuropsychological and
neurophysiological domains have been used to describe effects of
pesticides, lead (Pb), solvents, and mercury (Hg) in the workplace
and the general environment [4,5]. An attempt wasmade in 1983 to
standardize studies of neurotoxicants at a conference arranged by
the World Health Organization (WHO) and National Institute for
Occupational Safety and Health [6,7]. They recommended a battery
of seven neurobehavioral tests known as the WHO Neuro-
behavioral Core Test Battery (WHO-NCTB), and although these did
not become the gold standard for neuropsychological assessment
and have mostly not been adopted by psychological test publishers
in the United States or elsewhere, they are among the most
frequently used tests in the study of neurotoxic disorders. Many
of these tests have been characterized in normal populationsaluation Branch, 4676 Columbia Parkway, G15, Cincinnati, OH 45226, USA.
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ﬁndings may be difﬁcult [8] and their relevance to clinical disease
uncertain, but they can identify group differences [2,9e12]. Inno-
vation and efforts at consensus on standardization have continued
[2,13]. Health Canada [14] has grouped neurofunctional tests into
the following broad categories: (1) effects on motor function and
reaction time; (2) effects on cognition, memory, attention, and
sensory function; and (3) subjective symptoms and mood. In
reviewing 18 studies of Mn effects, Zoni et al [2] identiﬁed 64 tests
in 14 domains, which include: reaction time, eye-hand coordina-
tion, hand dexterity, tremor or steadiness, motor batteries, cogni-
tive functions, memory, mood, neurosensory functions, and
neurological endpoints. Standardized neurological examinations
such as the Uniﬁed Parkinson’s Disease Rating Scale [15,16]
(UPDRS) are also used, although, in some cases, neurobehavioral
tests appear to be reliable substitutes [17]. Use of neuropsycho-
logical and behavioral outcomes in large epidemiologic studies and
in risk assessments has been examined [9,18e20] with emphasis on
the distributional implications of small average decrements in
performance even in the absence of a deﬁned clinical syndrome or
known mechanistic basis. Small changes in scores on standardized
tests have been shown to be important, at the population level, for
real-life functions and capabilities. [21]
2.2. Effects observed with Mn
Cognitive, psychological, motor, and sensory effects have been
observed in welders with relatively low Mn exposures [22e28].
These ﬁndings are consistent with assessments in other Mn-
exposed populations such as battery production [8,29], ferroman-
ganese production [30e33], and ore processing [34,35]. Although
symptoms and deﬁcits vary, workers with elevated exposures
commonly reported headache, weakness, memory loss, sleep
disturbance, irritability, anxiety disorders, and gait disturbance.
These effects have been associated with Mn deposition in the brain
as measured with magnetic resonance imaging (MRI) in otherwise
normal industrial populations [25]. Early neuropsychological deﬁ-
cits have been clearly associated with chronic conditions such as
headache, muscle weakness, or memory loss [8,22,26,28,30,33,
34,36e42]. Aside from quality-of-life issues, these conditions may
impair work performance and safety. Some investigators reject
these ﬁndings [43e45]. Citing methodological problems in cross-
sectional studies, Jankovic [43] denies the value of neuropsycho-
logical testing for assessing adverse exposure effects and considers
some published reports with positive ﬁndings to be negative, such
as those of Myers et al [46] and Bowler et al. [47] Olanow [45] in the
legal arena has dismissed as insigniﬁcant “preclinical” effects in
Mn-exposed welders. This review will address these contentions.
2.3. Idiopathic Parkinson disease and Mn
Controversy remains about whether Mn-exposed workers have
increased risk of developing idiopathic Parkinson disease (PD)
[48,49] and whether the associated neurobehavioral and neuro-
logical signs and symptoms constitute early manifestations of
manganism [50]. Racette et al [51] reported welders have PD onset
at an earlier age than others, precipitating considerable interest in
Mn exposures. They examined 15 patients withmovement disorder
and welding experience and concluded that parkinsonism associ-
ated with welding is not clinically distinct from PD (although pa-
tients with atypical PD features had been excluded from their
series) [52]. Although they argued that there were no manifesta-
tions of manganism in the welders, others disagreed [53]. It is
unclear howmuch Mn exposure the 15 welders experienced. There
were no blood-Mn determinations; only two of the 15 welderswere evaluated with positron emission tomography (PET), showing
evidence of diminished dopamine uptake as in PD. Finding a
younger age at PD onset in welders is difﬁcult to interpret. Perhaps
welders report motor deﬁcits sooner (at a younger age) than others
as it affects their ability towork (manipulating a devicewith precise
hand-arm control). Older workers, when asked their occupation,
may be likely to say they are retired [54]. Some of the PD cases
could have had an overlay of early manganism symptoms resulting
in earlier detection of PD. An age-adjusted relative risk of PD in
welders was not calculable in the study design by Racette et al [51].
Other studies examining a Mn-PD link have been largely negative
or did not rule out manganism [55e62], although bias from the
healthy worker effect may have been present (see below). In a
recent study of dopamine uptake using PET scans, Criswell et al [63]
compared three groups (n ¼ 20 per group): normal volunteers,
asymptomatic welders, and patients with PD. The welders had
elevated blood Mn levels (mean: 20.7 mg/L), elevated pallidal index
indicating Mn deposition in the brain, and elevated UPDRS scores
despite being asymptomatic. Similar to the patients with PD, the
welders had signiﬁcant reductions in dopamine uptake but
exhibited a distinct pattern. Compared with patients with PD, they
showed a larger dopamine uptake deﬁcit in the caudate region of
the brain and a smaller effect in the anterior and posterior puta-
men, which the authors suggest could provide a physiological basis
for observed cognitive and behavioral abnormalities associated
with Mn exposure.
3. Issues in study design
3.1. Litigation series
As occurred with asbestos and benzene, litigation regarding
occupational Mn exposure has stimulated epidemiological inves-
tigation. Bowler et al [47] described a relatively large litigation
case series of welders and a comparison group consisting pri-
marily of individuals randomly selected from telephone di-
rectories. The source population and case identiﬁcation procedure
were not described. No speciﬁc welding fume exposure mea-
surements in air or biomarkers were available except for the
duration of welding years (mean ¼ 24.9 years). Participants, 76
welders and 42 controls, were evaluated for symptoms and
administered multiple neurobehavioral batteries in a blind
fashion. Welders did not perform as well as controls on verbal
learning, working memory, cognitive ﬂexibility, visuomotor
speed, and motor efﬁciency. Welders also had poorer emotional
status, impaired color vision, and increased prevalence of illnesses
and psychiatric symptoms. Symptoms and neurobehavioral deﬁ-
cits were correlated in the welders. Statistically signiﬁcant nega-
tive associations were reported between duration in welding and
verbal learning, auditory span, working memory, cognitive ﬂexi-
bility, and motor efﬁciency. Lees-Haley (who was hired by the
defense in welding rod litigation) et al [44] dispute the ﬁndings of
Bowler (who has worked for welding plaintiffs) et al [47], claiming
that the ambiguous case derivation limits etiologic inference.
Thus, the Bowler case series could merely represent a selection of
prevalent movement disorder or other neurobehavioral outliers
from a large welder source population that has a typical, expected
distribution of these outcomes. However, if that were the origin of
these cases, one would expect that PD would predominate among
those presenting with movement disorders. Goldman et al [56]
observed in a series of 2072 consecutive parkinsonism cases that
90% were PD. Tanner [60], in a similar clinical series of 519
parkinsonism cases, classiﬁed 97% as PD. However, Bowler et al
[47] identiﬁed no cases of PD for exclusion (believed not to be Mn-
related; personal communication). Self-selection by welders on
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plausible than on movement disorders. The Bowler case series
provides descriptive detail on likely Mn effects in a welder
population but does not permit quantitative estimates of excess
risk.
Bowler et al [64] evaluated a second litigation case series froman
uncharacterized regional population of welders in the southeastern
United States [65]. Forty-seven welders reported adverse mental,
medical, or neurological effects (15 were excluded due to unavail-
ability, illness, incomplete testing, poor vision, or potential malin-
gering) andwere comparedwith 42 controls (four exclusions; same
controls as used in Bowler et al [47]). All participants were admin-
istered an extensive array of neuropsychological tests by trained
neuropsychologists. A neurological examination by a board-certi-
ﬁedmovement disorder specialist in neurology included the UPDRS
rating scale, Part III, the motor subtest. The welders showed pro-
nounced deﬁcits in motor skills, visuomotor tracking, information
processing, working memory, verbal skills, and mood indicators.
This study, like the previous case series [47], had potential selection
bias preventing estimation of relative risk. However, the neurolog-
ical evaluation identiﬁed only a few possible cases of PD. Thirteen
symptomatic workers previously untreated for parkinsonism were
evaluated for levodopa responsiveness and none showed the strong
levodopa response expected for PD cases. [65]
Rohling and Demakis [66] compared the two case series by
Bowler et al [47,64] and reported that the estimated neuropsy-
chological effect sizes and the patterns of effects within each study
were different, concluding that the two studies do not support a
common pattern of neuropsychological impairment attributable to
Mn exposure. Rohling and Demakis [66] required two unsupported
assumptions: (1) that the studies had the same valid designs for
quantitative etiologic inference; and (2) that the exposure experi-
ence (duration, air concentrations, types of welding), was similar.
Moreover, the Rohling and Demakis analyses reveal considerable
consistency in deﬁcits in the Bowler studies, although the series by
Bowler et al [64] exhibited systematically higher levels of deﬁcit.
Given that the two series represent uncharacterized self-selection
of workers lacking documented Mn-exposure histories, the two
groups would not be expected to show the same levels of
impairment.
Although modest enhancements in study design and reporting
could improve the quality of some litigation-derived analyses,
Bowler et al [47,66] provide descriptive support for the association
of neurological effects and Mn exposure in two typical welder
populations. A third litigation-related series by Bowler et al [27,36]
consisted of a cross-sectional assessment of workers on a bridge-
welding project where no important selection bias could have been
present. [67]
Another litigation series consisted of 20,000 union welders
screened for neurologic abnormalities but the source population
was not adequately described [68]; 248 cases (1.2%) of PD were
found along with 583 cases (2.9%) of manganism. In an apparently
random sample of 37 of the manganism cases, measurements of
tremor indices were distinctly different from the published norms
for healthy controls: tremor intensity was elevated ﬁvefold. Bias
from selective recruitment of welders with movement disorders
was probably at most modest because the prevalence of PD in the
general population >60 years is 1.5e2%; the mean age of the
screened welders was 55 years so that the expected prevalence in
the screened population would be somewhat lower, as observed
(1.2%).68 Litigation series could be quite informative if information
that would enable an upper-bound estimate of selection bias were
reported. For example: How were participants solicited? How
many could have participated?3.2. Healthy worker effect
In occupational epidemiology, inappropriate comparison pop-
ulations can introduce healthy worker effect (HWE) bias [69,70].
Respiratory disease outcomes are especially vulnerable to this bias
as they relate to ﬁtness-to-perform work [70]; neurobehavioral
deﬁcits is another area where effect onwork-ﬁtness could generate
an important HWE. Evidence for the HWE in neurological outcomes
is apparent in several studies of Mn effects. Park et al [55] examined
by interview a large Korean PD case series in relation to occupation.
With the diagnosis made at ﬁve clinics beginning in 2001, 367
incident cases of PD agreed to participate (participation rate not
reported; an unknown number of all other forms of parkinsonism
were excluded). In a case-control design, incident cerebrovascular
controls were identiﬁed in the same clinics. After controlling for
age, education, sex, and smoking, occupations in manufacturing
showed a negative associationwith PD [odds ratio (OR)¼ 0.56, 95%
conﬁdence interval (CI) ¼ 0.34e0.92] suggesting selection away
from such work by workers at risk for PD, or, substantially elevated
cerebrovascular disease in those occupations. The associations of
PD with occupations tied to Mn exposure (welders, welding rod
manufacturing, Mn mining, and smelters; OR ¼ 0.42, 95%
CI ¼ 0.22e0.81) or in transportation occupations (OR ¼ 0.20, 95%
CI ¼ 0.06e0.71) were even smaller. Agricultural work and profes-
sional occupations exhibited elevated risks of PD as has been
observed elsewhere [57,60,71e74]. It is unlikely that a variation in
rates of cerebrovascular disease alone could explain these results.
Instead, they suggest a strong HWE with respect to PD in many
occupations and imply that a similar confounding bias would be
operating for other forms of parkinsonism. The study was unin-
formative on the question of early manganism in Mn-exposed
workers as this and other forms of non-PD parkinsonism were
excluded.
Fryzek et al [75] linked the Danish National Register of Patients
(hospital admission and outpatient records) with a cohort from
stainless and mild steel metal manufacturers in order to study
welding and parkinsonism. Standardized hospital admission ratios
(SHR) were calculated. For all welding department workers the SHR
for PD was 1.0 (95% CI ¼ 0.7e1.5) and for actual welders it was 0.9
(95% CI ¼ 0.4e1.5), exhibiting a possible deﬁcit as observed by Park
et al. [55] Fored et al [76] conducted a population-based (gainfully
employed) assessment of the incidence of parkinsonism and
related movement disorders among welders in Sweden by linking
hospital discharge diagnoses with census data. Among almost
50,000 welders and ﬂame cutters, there was a slight deﬁcit in PD
incidence [relative risk (RR)¼ 0.89, 95% CI¼ 0.79e0.99], replicating
the observations of Park et al [55] and Fryzek et al [75] and sug-
gesting that the welder workforce in general has favorable neuro-
logical status and thus would be subject to the HWE.
Marsh and Gula [59] were commissioned to analyze “idiopathic
Parkinson’s disease, parkinsonism or a related neurological disor-
der,” at three Caterpillar heavy equipment manufacturing plants,
using medical insurance claims. They classiﬁed workers as ever or
never performing welding work (including “electrode” or resis-
tance welding as well as other “fabrication” jobs that may not
confer Mn exposures). The outcome of primary interest selected by
the investigators was PD [International Classiﬁcation of Diseases,
Ninth Revision (ICD-9): 332.0]. Using two sets of matched controls
(10:1), the investigators observed ORs for incident cases of PD of
0.76 (95% CI ¼ 0.26e2.19) and 0.81 (95% CI ¼ 0.29e2.25), respec-
tively. For prevalent cases, they observed ORs of 0.82 and 0.97,
respectively. Thus, compared to other workers, the group including
welders had a less-than-expected association with PD, further
supporting the concern over bias arising from the HWE in
Saf Health Work 2013;4:123e135126occupational studies of neurological outcomes in groups with
special skills.
Ellingsen et al [28] studied workers with at least 1 year of
employment as a welder at two large shipbuilding and machine
manufacturing enterprises in St. Petersburg, Russia. In addition, 27
from a case series of 37 workers compensated for welding-related
manganism (a compensable occupational disease in Russia) from a
St. Petersburg clinic were examined. Welders in groups with
increasing Mn exposure exhibited substantially lower performance
on Digit Symbol and Finger Tapping than referents, and welders as
a group had nonsigniﬁcantly elevated symptoms, but performed
better on hand steadiness. As the authors observed, hand steadi-
ness, an attribute of considerable importance to welders, may
exhibit healthy worker bias (or perhaps worker skill bias), which
would tend to confound comparisons with nonwelders and cause
an underestimation of Mn effects.
For a mortality study of neurodegenerative disease deaths in the
United States during 1985e1999, Stampfer [61] used the Cause of
Death database of the US National Center for Health Statistics and
observed adjusted mortality odds ratios for PD of 0.85 (95%
CI ¼ 0.77e0.94) and 0.83 (95% CI ¼ 0.78e0.88) in welders, using
two deﬁnitions of welding occupations [61]. This supports the
presence of a signiﬁcant HWE among welders. An even stronger
effect was observed in welders for motor neuron disease (amyo-
trophic lateral sclerosis, OR ¼ 0.71, 95% CI ¼ 0.56e0.89), a chronic
condition that clearly would affect welders’ ability to work.
Neurobehavioral studies of skilled workers using the general
population as a reference are likely to be subject to healthy worker
biases because skilled welders may require above average visuo-
motor skills. If the HWE were as large as 10% for neurobehavioral
outcomes in welders (i.e., for an adverse outcome, RR ¼ 0.9 in the
absence of Mn exposure), and if the proportion of welders exposed
to levels of Mn associated with deﬁcits that have been observed
(i.e., above 0.3 mg/m3 Mn) were as small as 2%, then very high RRs
(RR > 5, from 0.02  RR  0.90 ¼ 0.10) in the group exposed above
0.3mg/m3would be required prior towhen the RR of welders in the
aggregate would exceed 1.0, and much higher relative risks in the
exposed (>30) would be needed to achieve an elevated RR of 1.5 in
the aggregate. The likely presence of HWE in large surveillance-
type studies and in others using general reference populations
could obscure important associations in occupational studies of
environmental etiologic agents.
3.3. Statistical power
Several published studies have had limited statistical power to
address a Mn association with non-PD parkinsonism. Among
welders in the Danish study of Fryzek et al [75] (comprising 22% of
the study population), there were 11 cases of PD and only four cases
of other parkinsonism or related neurodegenerative disorders
(including two cases of dystoniaealtered muscle tone and
mobility). Without actual Mn exposure data, this study would have
very limited statistical power for detecting an excess of non-PD
parkinsonism in welders. In the population-based hospital
discharge study of Swedish welders by Fored et al [76], there were
383 incident cases of parkinsonism of which 353 cases were of PD
(92%) and 30 cases (7.8%) were of other parkinsonism: extrapyra-
midal and movement disorders (n ¼ 26) and dystonia (n ¼ 4). An
analysis of RR for non-PD parkinsonism with welding was not re-
ported but could have had limited power because of: (1) the HWE
observed there for all movement disorders (RR ¼ 0.91), and (2) the
absence of type-of-welding information at the individual level,
which would help identify high-exposure groups. Furthermore,
cases likely to result in hospitalization would have relatively
advanced parkinsonism, whereas Mn-related disease may beinherently self-limiting because signiﬁcant impairment would lead
to termination of employment as welders. A statistically nonsig-
niﬁcant elevation was observed for the four welders in whom
dystoniawas diagnosed (RR¼ 1.42), a manifestation of manganism.
In the clinical series of Goldman et al [56], 90.5% of 2249
movement disorder cases had a diagnosis of PD, including the three
cases whose primary lifetime employment was welding. The ex-
pected number of non-PD parkinsonism among those welders
would have been 0.29 [¼(1-0.905)  3]; therefore the study had
minimal power to detect an excess of non-PD parkinsonism in
welders. In the clinical series of 519 movement disorder cases by
Tanner [60], 97% were PD and 41 of 519 were ever welders (a much
higher proportion e by a factor of 60 e than in Goldman et al [56],
where longest-duration occupation was used). In this case-control
design, there was no association of parkinsonism with ever-weld-
ing (OR ¼ 1.01), implying that about 97% of both welders and
nonwelders with parkinsonism had a diagnosis of PD and that the
number of non-PD parkinsonism cases expected among the 41
welders was about 1.2 [¼(1e0.97)  41], implying that this study
also had limited statistical power for addressing the manganism
hypothesis. However, if a 10% HWE were present (less likely for
“ever-welders”), then there would be a relative risk of 1.01/
0.9¼ 1.12 for parkinsonism inwelders, and if therewas no excess of
PD in welders, then the 12% excess risk would correspond to a
considerably higher relative risk for non-PD parkinsonism in
welders. Thus, several studies of neurological impairment in
welders that have been reported and cited as “negative” had
limited statistical power, which should be explicitly acknowledged.
3.4. Exposure and model speciﬁcation
Some studies used analytical strategies that were not favorable
toward identifying a true association of Mn with neurological def-
icits. Kim et al [23] studied neurobehavioral performance in 121
workers involved in welding, steel alloy production, and welding
rod manufacturing in Korea. Three groups deﬁned by current total
airborne Mn concentrations were compared: “unexposed”
(<0.01 mg/m3), low (0.01e0.10 mg/m3), and high (>0.10 mg/m3).
All three groups had elevated blood-Mn (MnB) with the levels
increasing with Mn exposure but not statistically signiﬁcantly.
Regression models were ﬁt for diverse neurobehavioral outcomes
using all predictors and risk factors as independent variables
including Mn (air), Mn (blood), Mn (urine), and MRI scores for Mn
deposition in the brain. Finger Tapping deﬁcits were signiﬁcantly
associated with airborne Mn but the trends for Finger Tapping,
Digit Span, Digit Symbol, Pursuit Aiming, and Simple Reaction Time
across levels of exposure were not signiﬁcant. These models may
not have been optimal for estimating the Mn exposure response
because including other causal-path variables in the model [Mn
(blood), MRI scores] could have reduced exposure effect-estimates.
Abnormal neurological signs (tremor, muscle rigidity, bradykinesia,
or postural instability) were observed in 9.1% (two cases) of the
“unexposed” comparison group, which also had elevated MnB
levels (11.9 mg/L), suggesting that some individuals in the unex-
posed group had signiﬁcant prior exposure to Mn.
Myers et al [46] conducted a cross-sectional neurobehavioral
study comparing South African ferroalloy smelter workers with
workers in electrical ﬁttings manufacturing not exposed to Mn. The
plant process areas were classiﬁed in three levels of current inhal-
ableMnexposure: high> 2.0mg/m3 (n¼ 201),medium0.1e2.0mg/
m3 (n¼ 201), and low< 0.1mg/m3 (n¼ 107). ThemeanMn in blood
was 12.5 mg/L in the ferroalloy workers versus 6.4 mg/L in the elec-
trical workers, and the mean Mn (urine) was 10.5 mg/L versus
0.96 mg/L, respectively. Statistically signiﬁcant declining perfor-
mance scores were observed with cumulative exposure classiﬁed
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Santa Ana dexterity, reaction time, and Finger Tapping tests.
Although the parameter estimate for a linear effect on Digit Span
was highly signiﬁcant (p ¼ 0.001), most of the outcomes did not
exhibit statistically signiﬁcant linear trends, perhaps because much
of the performance decline had already occurred within the lowest
cumulative exposure category, resulting in a nonlinear relationship
over the observed range of cumulative exposure. For example, with
the Santa Ana dexterity test most of the deﬁcit with increasing cu-
mulative exposure had occurred by 1.3 mg/m3eyears, in the lowest
exposure category. A metric like the square-root of cumulative
exposure could have been more appropriate. Large differences in
comparisons using internal versus external controls suggest either
that there was residual confounding in spite of age, education, and
home language being controlled, or that the processes thought to
have low exposure and used to deﬁne the internal referent group
may have had important Mn exposures, as suggested in the Santa
Ana dexterity, Benton, and Digit-symbol regression results. A com-
posite score of clinical abnormalities was signiﬁcantly elevated
comparing the medium- and high-exposure workers with the low
exposure group (one or more abnormalities: OR ¼ 3.7, 95%
CI¼ 1.1,13), and a signiﬁcant trend of the clinical abnormalities score
across quartiles of MnB was also observed. However, these in-
vestigators concluded that there was “little convincing evidence for
a continuum of effects.” related to Mn [46], and reviews of this
study have inexplicably interpreted it as negative. [43,49] Further
examination of the neurobehavioral exposure responses in this
population conﬁrmed the nonlinearity of the responses but the in-
vestigators focused more on fortuitous and inappropriate linear
estimates than on characterizing and interpreting the nonlinear
response as strong evidence for a substantial Mn effect. [77]
In the litigation series of 20,000 screened welders [68] where
therewasminimal likelihoodof strong selection bias and statistically
signiﬁcant increased tremor intensity, regression models using 37
welders were ﬁt on age, as a surrogate for cumulative Mn exposure.
The trends were not signiﬁcant. A more powerful analysis would
have incorporated into the model as ﬁxed intercepts the expected
age-speciﬁc values for tremor derived from population norms.
Some studies investigating whether Mn exposures that cause
PD have indirectly or inadvertently addressed the association with
non-PD parkinsonism. Park et al [58] investigated PD in 24,963
blue-collar workers and 13,597 white-collar workers employed for
at least 12 months at two Korean shipyards, linking records to the
national medical insurance database. Study participants were
classiﬁed as: (1) welders, (2) cutting, grinding, ﬁtting, and ﬁnishing,
and (3) other (painting, plating, drilling, maintenance). The geo-
metric mean for air samples (n ¼ 165) in welders was 0.88 mg/m3
Mn and in cutters, ﬁtters, etc. it was 0.10 mg/m3 (n ¼ 41). A
neurologist identiﬁed only nine new PD cases (ICD-10: G20) among
the 115 workers with 475 insurance claims coded as ICD10: G20e
G26 (extrapyramidal and movement disorders). The crude (not
age-adjusted) rates of PD were very close comparing the blue- and
white-collar populations but using Cox regression adjusting for age,
the investigators estimated the relative risk for PD among the blue-
collar workers to be 4.19 (95% CI ¼ 0.96e18.3), statistically signif-
icant as a one-tailed test. Based on the exposure classiﬁcation,
however, the high exposure group (welders, two cases; RR ¼ 1.96)
and the low exposure group (painters, maintenance, etc., four
cases; RR ¼ 3.65) were not signiﬁcantly different (although the
parameterization of the model is not entirely clear). With small
numbers of exposed cases this study is not informative on whether
welding with Mn exposures is a risk factor for PD. However, the
large number of non-PD parkinsonism cases identiﬁed (n ¼ 106;
92% of 115 parkinsonism cases) is in sharp contrast to studies based
on hospitalization or tertiary clinic series where PD dominates theparkinsonism picture [56,60] and suggests excess movement dis-
orders in these shipyard workers. Analysis of these 106 non-PD
cases in relation to past exposure would have been quite revealing.
In theMarsh and Gula [59] study of welders in heavy equipment
manufacturing, no PD excess was observed. Due to concern that
misdiagnosis could occur, the investigators deﬁned a second
expanded group of cases to include “other degenerative diseases of
the basal ganglia” and “essential or other speciﬁed forms of tremor”
(ICD-9: 333.0 and 333.1, respectively). With the expanded case
deﬁnition, slightly larger ORs were observed. The investigators did
not analyze separately the non-PD parkinsonism cases used to
expand their deﬁnition, which are some of the speciﬁc forms of
parkinsonism in which manganism might be coded. However, one
can ascertain the numbers of these case incidents among welders
(n ¼ 26) and nonwelders (n ¼ 12) by comparing Tables 2 and 4 in
Marsh and Gula [59] and calculating an OR (disregarding matching)
to obtain OR ¼ 1.69 (95% CI ¼ 0.81e3.6). A more accurate, adjusted
estimate would result from a matched analysis (not possible with
the data reported). This result suggests that welding-(Mn)-related
parkinsonism is present in this population and might be evident in
analyses using estimates of cumulative or recent (5 year) Mn
exposure. Implemented as a test for welding and PD, this study has
been interpreted as negative.
From a mortality analysis of US welders, Stampfer [61]
concluded that there were no elevations among welders for
neurodegenerative conditions. However, in this study, which did
not account for a HWE, presenile dementia was marginally signif-
icantly elevated (above a baseline of 0.9) and deaths amongwelders
due to other diseases of the basal ganglia were elevated by 16e25%
but based on small numbers. A key issue in assessing welding as a
risk factor for mortality, of course, is identifying the general health
consequences of manganism at a moderate level of progression,
possibly arrested by termination of exposure.
4. Summary of neurobehavioral ﬁndings
The literature prior to 2000 documenting health effects in
workers exposed to Mn in mining, ferroalloy production, welding,
and manufacturing using standardized neuropsychological or
neurobehavioral endpoints has been reviewed [78]. More recent
reviews include Antonini et al [48], Santamaria et al [49], McMillan
[79], Zoni et al [2], and Greiffenstein and Lees-Haley [80] (meta-
analysis). The epidemiologic studies of Mn-exposed workers that
address the association of Mn exposure with various health effects
related to the nervous system, are displayed in Table 1 [8,22e
35,37e42,46,82e84]. Some studies focus on neurobehavioral test
endpoints, others on symptoms, but many address both. The
observed Mn exposure levels are often below 0.2 mg/m3.
Twenty-eight published reports have contrasted likely or deﬁ-
nitely Mn-exposed workers with generally comparable groups of
unexposed industrial workers (Table 2) [8,22e35,37e42,46,58,59,
67,68,81e88]. These reports use diverse outcomes, exposure as-
sessments, and study designs, making them difﬁcult to rank on
weight of evidence; they are displayed here beginning with those
having a continuous Mn exposure metric followed by those with
categorical exposure classiﬁcations in order of diminishing number
of exposure strata. Statistically signiﬁcant performance deﬁcits or
symptom excesses among the Mn-exposed workers have been
observed in almost all studies. In some cases the comparison
groups may have had some signiﬁcant past or current Mn exposure,
which would diminish the estimated Mn-effect [22,24,34,
37,39,41,42,82]. Eleven of these studies observed statistically sig-
niﬁcant trends with continuous measures of Mn exposure or MnB
using correlations, multiple regression, or logistic regression pro-
cedures. Seventeen studies relied on categorical comparisons, 11
Table 1
Manganese study populations with neurobehavioral effects: Mean airborne exposure concentrations (in chronological order)
Study Work n Total Mn, mg/m3
am gm (med) Range/SD
Roels et al 1987 [8] MnO/salts pdn 141 1.33 0.94 0.07e8.61
Wang et al 1989 [41] Ferroalloy 68 e e 0.10
24 0.50e1.50
8* 28.8*
Iregren 1990 [81] Foundry 30 0.25y (0.14) 0.02e1.40
Sjogren et al 1990 [82] Welding e e e e
Roels et al 1992 [29] MnO/battery 92 1.78 0.95 0.05e10.8
Chia et al 1993 [34] Ore crushing e 0.70 e e
Mergler et al 1994 [30]
Bouchard et al 2007 [40]
Ferro/silico Mn 115 1.19 0.23 1.05z
Kim et al 1994 [39] Ferroalloy 90 e 0.60 2.3x
Chia et al 1995 [35] Ore crushing 1.59 e e
Lucchini et al 1995 [31] Ferroalloy
- Med 19 e 0.12 0.07e0.62
- High 20 0.27 0.12e0.65
Sjogren et al 1996 [22] Welding 68 e e e
Lucchini et al 1997 [32] Ferroalloy 35 e (0.44) 0.26e0.75
Lucchini et al 1999 [33] Ferroalloy 61 0.18 0.05 0.01e1.49
Gibbs et al 1999 [83] Electrolytic Mn 75 0.18y 0.11 e
Jin et al 1999 [38] Welding 2.10y e 0.005-9.3
Kim et al 1999 [23] Welding 23 e e 0.01e0.10
76 >0.10
Moon et al 1999 [24] Welding 60 0.17 0.15 1.7x
Deschamps et al 2001 [37] Pigments 139 2.05 e 0.50e10.2
Sinczuk-Walczal et al 2001 [84] Battery welding 75 0.39 0.15 0.54
Myers et al 2003 [46] Ferroalloy 509 0.82y e 1.04
Beuter et al 2004 [85] Ferroalloy 10 e e e
Kim et al 2005 [25] Welding (auto, steel, ship)
smelter welding rod mfr
111 e 0.50 3.7x
Yuan et al 2006 [26] Welding (machine manufacturing) 68 0.14 e 0.04e0.20
Wang et al 2006 [42] Welding 82 0.25 e 0.10e0.50
Bowler et al 2007 [27] Welding (bridge) 48 0.19 0.14 2.3x
Ellingsen et al 2008 [28] Welding 96 e 0.12 0.007e2.3
am, arithmetic mean; gm, geometric mean; med, median; SD, standard deviation.
* Exposures of 30 min. per day during electrode maintenance.
y Inhalable dust.
z 75th percentile.
x Geometric SD.
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tests of trend across Mn exposures classiﬁed into two or three
levels based on duration of welding, estimated cumulative expo-
sure, or current exposure level (Table 2).
Case-control and cross-sectional studies of workers exposed to
Mn in several occupations have identiﬁed psychomotor and motor
function effects as well as cognitive effects [8,22e28,30e35,
38,39,41,42,46,81,82,85]. These results are relatively consistentacross all studies. The frequently observed ﬁndings on neuro-
behavioral test associations (e.g., ﬁnger tapping, eye-hand coordi-
nation, Digit Symbol, Digit Span, Santa Ana Dexterity) demonstrate
that these deﬁcits can be readily measured using standardized tests
in these Mn-exposed populations. Although symptoms and deﬁcits
vary, common symptoms include headache, weakness, slowed
movement, memory loss, sleep disturbance, irritability and anxiety
disorders, loss of libido, and gait disturbance.
Table 2
Summary of investigations observing statistically signiﬁcant associations between Mn exposure status and motor, cognitive, or symptom outcomes (in order of type of
exposure response and year of publication)
Study/work n P I M C D R Hand-eye coordination,
motor/postural
Cognitive, mood,
autonomic/other
Symptom Exposure response
Continuous exposure metric
Roels et al, 1987 [8] MnO/
Mn salts pdn
141 Ch 1 1 0 0 1 Eye-hand coordination
Hand steadiness
Simple Reaction
Time
Tremor (ﬁngers)
Rigidity (neck, trunk)
Fatigue
Irritability
CONT; CAT[2]
Roels et al, 1992 [29]
MnO/battery
92 Mf 1 1 0 0 1 Eye-hand coordination
Hand steadiness
Visual Reaction
Time
Tremors
CONT; CAT[4]
Lucchini et al, 1995 [31]
ferroalloy
19
20
Fe 1 1 1 1 1 Finger Tapping Addition
Symbol Digit
Digit Span
CONT; CAT[3]
Lucchini et al, 1997 [32]
ferroalloy
35 Fe 1 1 1 0 1 Aiming Pursuit II CONT; CAT[2]
(increased
olfactory acuity
with inc. Mn(U))
Sinczuk-Walczal et al,
2001 [84]
battery/welding
75 Wl 1 0 0 0 1 Irritability
Paresthesia
Sleepiness
CONT; CAT[2]
Myers et al, 2003 [46]
ferroalloy
509 Fe 1 1 1 1 1 Santa Ana
Dexterity
Digit Symbol
Digit Span
Benton Visual
Retention
CONT; CAT[3]
Kim et al, 2005 [25]
welding (mfr), smelter,
welding rod mfr
111 Wl
Mf
1 1 1 0 1 Factor: psychomotor Factor: affect, factor:
attention-memory
CONT (structural
equation model)
Wang et al, 2006 [42]
welding
Wl 1 1 1 1 1 Simple Reaction
Time
Digit Span total,
forward, backward
Anger-hostility
Fatigue-inertia
Headache
Dizziness
Concentration
Weakness
CONT; CAT[2]
(Pb confounded)
Park et al, 2006 [67]
Park et al, 2009 [86]
welding
48
44
Wl e e e e e Working Memory
Index
Verbal IQ
Stroop Color-word
CONT (duplicates
Bowler, 2007)
Bowler et al, 2007 [27]
welding
43 Wl 1 1 1 0 1 Tremors Executive function
Verbal learning
Working memory
Concentration and
sequencing
Immediate memory
Fatigue
Sleep disturbance
Depression
Anxiety
Numbness
CONT; CAT[2]
Ellingsen et al, 2008 [28]
welding (shipyard,
heavy machinery)
Wl 1 1 1 1 1 Finger Tapping Digit Symbol NCTB Q16 CONT; CAT[2]
Wastensson et al, 2011
[87]
17 Wl 1 1 0 0 1 Pegboard CONT; CAT[2]
Categorical exposure metric in four levels
Wang et al, 1989 [41]
ferroalloy
68
24
8
Fe 1 1 1 0 0 Bradykinesia
Rigidity
Gait abnormality
Weakness
Dislike of talking Fatigue
Loss of libido
CAT[4]
Sjogren et al, 1990 [82]
welding
e Wl 1 0 1 0 0 NCTB Q16: nervous
system symptoms
CAT[4]
(continued on next page)
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Table 2 (continued )
Study/work n P I M C D R Hand-eye coordination,
motor/postural
Cognitive, mood,
autonomic/other
Symptom Exposure response
Mergler et al, 1994 [30]
Bouchard et al, 2007
[40] ferro/silico Mn
38 Fe 1 1 1 0 0 Luria Total Score
Finger Tapping
Graphomotor Nine
Hole Steadiness
Profuse sweating
Memory loss
Agitation
Anxiety
Fatigue
Nightmare
POMS [11]
CAT[2] (matched)
CAT[4] (matched)
Jin et al, 1999 [38]
welding
na Wl 1 1 1 0 0 Pursuit Aiming
Finger Tapping
Santa Ana
Dexterity
Inability to
concentrate
Muscle symptoms
Neurological
symptoms
CAT[4]
Lucchini et al, 1999 [33]
ferroalloy
61 Fe 1 1 1 1 0 Finger Tapping
disequilibria tremors
Addition
Digit Symbol
Digit Span
Irritability CAT[4]
Categorical exposure metric in three levels
Kim et al, 1999 [23]
welding
23
76
Wl 1 1 1 1 0 Pursuit Aiming
Finger Tapping,
Santa Ana
Dexterity
Digit Symbol
Digit Span
CAT[3]
Park et al, 2006 [58]
welding
Wl e e e e e Parkinson disease,
parkinsonism
CAT[3] (vicarious
ﬁnding*)
Categorical exposure metric in two levels
Iregren, 1990 [81]
foundry
30 Fe 1 1 1 1 0 Finger Tapping
Simple Reaction
Time
Digit Span CAT[2]
Chia et al, 1993 [34]
ore crushing
e Or 1 1 1 1 0 Pursuit Aiming Benton Visual
Retention
Digit Symbol
20 of 37 adverse
symptoms
insomnia
CAT[2] (motor
speed, visual
scanning,
visuomotor
performances)
Kim et al, 1994 [39]
ferroalloy
145
49
90
Fe 1 1 0 0 0 Difﬁculty writing Reduced libido CAT[2,2]
Chia et al, 1995 [35]
ore crushing
e Or 1 1 0 0 0 Postural sway
(eyes closed)
CAT[2] (two
postural stability
parameters)
Sjogren et al, 1996 [22]
welding
68 Wl 1 1 1 0 0 Finger Tapping
Pegboard
Luria Nebraska
(items 2, 22)
NCTB Q16: inability
to concentrate
memory loss
NCTB Q16:
depression
CAT[2]
Moon et al, 1999 [24]
welding
60 Wl 1 1 1 0 0 Tremors
Gait disturbance
Amnesia
General weakness
Speech disturbance
CAT[2]
Gibbs et al, 1999 [83]
electrolytic Mn
75 Ch 0 0 0 0 0 Reaction time
Gait disturbance
Memory loss Sleep disturbance CAT[2]; CONT (no
effects on
individual
measures but 5/7
show
nonsigniﬁcant
deﬁcits)
Deschamps et al, 2001
[37] pigments
30 Ch 1 0 0 0 0 Asthenia Headache
Sleep disturbance
CAT[2]
Beuter et al, 2004 [85]
ferroalloy
10 Fe 1 1 0 0 0 Postural tremor CAT[2] (tremor
parameters)
Yuan et al, 2006 [26]
welding (machine mfr)
68 Wl
Mf
1 1 1 1 0 Pursuit Aiming
reaction time
(improved)
Digit Span
Digit Symbol
Depression-dejection
Tension-anxiety
Vigor-activity
Fatigue-inertia
CAT[2]
Marsh et al, 2006 [59]
heavy equip mfr
Wl e e e e e Parkinson’s disease,
parkinsonism
CAT[2] (vicarious
ﬁnding*)
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Table 2 (continued )
Study/work n P I M C D R Hand-eye coordination,
motor/postural
Cognitive, mood,
autonomic/other
Symptom Exposure response
Chang et al, 2009 [88]
ship building
43 Wl 1 1 1 1 0 Finger Tapping
Pegboard tremors
Hand coordination
Digit Symbol
Digit Span
Stroop
Complex ﬁgure
CAT[2] ; CONT (on
pallidal
index)
Sanchez-Ramos et al,
2011 [68]
welding: shipyard,
reﬁnery
37 Wl 1 1 0 0 0 Tremors CAT[2]
TOTALS 28 25 19 10 11
C, cognitive outcomes (1 ¼ yes, 0 ¼ no); Ch, chemical; D, Digit Symbol/Digit Span deﬁcits (1 ¼ yes, 0 ¼ no); Exposure response, a reasonably well-designed comparison, using
either continuous (CONT) or categorical [CAT (levels)] models of exposure response; Fe, ferroalloy; I, Include as positive study (1 ¼ yes, 0 ¼ no); M, motor outcomes (1 ¼ yes,
0 ¼ no); Mf, manufacturing; n, size of study group; NCTB, Neurobehavioral Core Test Battery, developed by WHO, with symptom questionnaire (Q16); Or, ore processing;
P, Process; POMS, Proﬁle of Mood States; R, continuous exposure metric showing exposure response (X-R) (1 ¼ yes, 0 ¼ no); Wl, welding.
* Proposed interpretation of published data regarding parkinsonism other than Parkinson’s disease.
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neurobehavioral effects in several welder studies [23,25e
28,38,42,82] and also in nonwelder Mn-exposed workers [8,29,31e
33,46,81]. The association of these effects with Mn deposition as
measured with MRI and the pallidal index in otherwise normal
industrial populations [25] adds further support that these are
associated with Mn exposure.
Motor effects were identiﬁed using neurobehavioral tests in 25
reports, including tests of simple reaction time, eye-hand coordi-
nation including Santa Ana dexterity, Finger Tapping, pursuit and
the Luria motor tests, and measures of tremor and sway (Table 2).
Cognitive effects were reported in 19 studies, including 10 using the
standardized Digit Symbol and Digit Span tests. Of the 28 studies
reporting an association between occupational exposure to Mn and
neurobehavioral deﬁcits or symptoms/signs of parkinsonism, 14
involved welders and nine involved high-temperature metallur-
gical processes producing a plausibly similar respirable Mn-con-
taining fume.
One published study with individual Mn exposure data and a
comparable comparison group of unexposed workers failed to
observe statistically signiﬁcant deﬁcits in neurobehavioral perfor-
mance [83]. A slowing in median reaction time was signiﬁcantly
associated with age but nonsigniﬁcantly associated with cumula-
tive Mn exposures over the past month, year, or lifetime. The Mn
exposures in that study were quite low and mostly nonrespirable
(mean total ¼ 0.18 mg Mn/m3; mean respirable ¼ 0.066 mg Mn/
m3), and possibly negatively confounded by shift work (the com-
parison population had more shift work, observed by these in-
vestigators to be associated with neurobehavioral deﬁcits).
4.1. Study limitations
There are limitations in many of the etiologic studies onwelders
and other occupations exposed to Mn. Most are cross-sectional in
design and thus are vulnerable to survivor bias (e.g., workers with
developing symptoms and deﬁcits more likely to leave employ-
ment). Some studies with external reference populations exhibited
HWE bias. Methodological details are sometimes lacking, particu-
larly on the selection and participation of study populations; past
exposures and work histories were not usually known and in many
cases there is limited information on current exposures. In studies
where exposure response was estimated, study limitations such as
HWE, survivor bias, or exposuremisclassiﬁcationwould be unlikely
to cause false associations andwould cause underestimation of true
associations and exposure response.4.2. Confounding exposures
Confounding exposures may exist during welding or furnace
operations, such as carbon monoxide (CO), aluminum, Pb, and heat
stress, all of which could affect neurobehavioral performance in
cross-sectional research [12]. CO is a neurotoxicant at very high
levels, as in acute CO poisoning cases. In a series of 65 cases of
severe CO poisoning, frequently resulting in loss of consciousness
or coma, one or more signs or symptoms of parkinsonism were
present in 80% of cases, typically developing days or weeks after
recovery from coma [89]. In a series of eight patients evaluated at a
Baltimore hyperbaric oxygen treatment center for chronic CO
poisoning, usually caused by defective appliances, nervous system
deﬁcits were very evident but at least partially reversible [90].
Sustained exposures at levels exceeding 200 ppm were suspected
but not documented. Symptoms associated with CO exposure
concentrations of 100e200 ppm include headache, nausea, and
mental impairment [91]. However, CO in most welding and other
Mn environments is not generally elevated above levels commonly
present in industry (e.g., 25 ppm). Park et al [67] reported that peak
values for continuously monitored CO levels in bridge welders
working in conﬁned spaces were below 20 ppm in almost all in-
tervals. In a study of Taiwanese smelter workers where substantial
neurological impairment was observed, the average CO levels at the
offending furnace were 25e60 ppm, including levels at the top of
the furnace where exposures were brief [41]. Other metals with
known or potential neurotoxic effects such as Pb, copper, cadmium,
and aluminum are usually absent in mild or stainless steel welding
activities with Mn exposures. One of the 25 studies with positive
ﬁndings reported possible confounding by lead but blood levels
were low (geometric mean ¼ 11.7 mg/dL Pb) [42]. Thus, other metal
and especially CO exposures are unlikely to be conferring important
confounding bias in the Mn studies discussed here.
5. Contrarian reviews
Greiffenstein and Lees-Haley [80] conducted a meta-analysis of
19 studies examining Mn and neuropsychological effects in the
published literature, based on the following assumptions or meta-
analytic procedures: (1) setting to null rather than excluding any
effect not statistically signiﬁcant that was lacking sufﬁcient statis-
tical detail to calculate an effect size (four studies; the goal of meta-
analyses is to statistically combine effects with known uncer-
tainty); (2) discounting associations with an effect size smaller than
that of the potential confounder, education (years), in comparing
Table 3
Comparison of adverse neurobehavioral effect magnitudes for neurotoxic metals: fractional score change*
Study Finger tapping Symbol digit Digit symbol Digit span Peg board Trail-B Hand steadiness Santa ana Wisconsin
total error
Mercury (per mg/m3-yr of cumulative exposure)
Ngim et al, 1992 [100] 0.291 0.582 e 0.885 0.185 1.277 e e e
Liang et al, 1993 [101] 0.146 0.431 e e e e e e e
Piikivi et al, 1989 [99] 0.096 0.188 e 0.127 e e e e e
Lead (per measures based on bone/blood lead)
Stewart et al, 1999 [97] y 0.029 0.024 e 0.052 0.017 e e e e
Chia et al, 1997 [102] z e e 0.244 e 0.159 0.496 e 0.089 e
Barth et al, 2002 [103] z e e 0.025 e e e e 0.307
Lindgren et al, 1996 [104] x 0.018 0.022 0.036 0.016 0.065 e e e
Manganese (per mg/m3-y of cumulative exposure)
Lucchini et al, 1995 [31] 0.095 0.374 e 0.227 e e e e e
Ellingsen et al, 2008 [28] 0.016 e 0.026 0.036 0.004 e 0.125 e e
Wastensson et al, 2012 [87] 0.0005 e e e 0.023 e e e e
Mergler et al, 1994 and
Baldwin et al, 2008 [30,105]
0.011 0.004 e 0.010 e 0.036 0.089 e e
Lucchini et al, 1999 [33]-high 0.017 0.039 e 0.028 e e e e e
Lucchini et al, 1999 [33]-mid 0.058 0.144 e 0.183 e e e e e
Kim et al, 1999 [23]-high 0.072 e 0.225 0.151 e e e 0.042 e
Kim et al, 1999 [23]-low 0.438 e 1.206 0.369 e e e e e
Iregren, 1990 [81] 0.029 e e 0.035 e e e e e
Yuan et al, 2006 [26] e e 0.079 0.053 e e e e e
Chang et al, 2009 [88] 0.034 e 0.040 0.084 0.040 e e e e
* Calculated as: (1) for discrete analyses, difference in score between exposed and unexposed group divided by control group score and by average cumulative exposure, or
(2) for regression-based results, estimated effect at 1 mg/m3-year divided by intercept or nominal baseline normal score.
y Using normal baseline levels and based on average observed community tibial bone lead levels.
z Based on change per 250 mg/dLeyear of cumulative lead blood level.
x Based on change per 250 mg/dLeyear of cumulative lead blood level comparing two groups: 268 versus 1227 mg/dLeyear Pb (mean lead¼ 26.1 vs. 52.8 mg/dL, respectively).
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as few as two studies in the meta-analyses for speciﬁc outcomes,
usually less than ﬁve (14 outcomes out of 26), and never more than
10; (4) assuming homogeneity of exposure attributes and of time
courses of exposures across studies; (5) excluding analyses relying
on internal comparisons, e.g., with continuous exposure classiﬁ-
cation; and (6) disregarding issues of reversibility or adaptive
changes. Using this approach a meta-analytic summary of the
diverse studies analyzed could be uninformative. Even with these
restrictions, 15 of 26 tests meta-analyzed showed statistically sig-
niﬁcant summary effects sizes with Digit Span having the strongest
association. Nonetheless the authors conclude that “the data did
not support a theory of preclinical (‘early’) neuromotor or cognitive
dysfunction.”
Santamaria et al [49] reviewed the available literature on case
reports and epidemiologic investigations of welders. They
concluded that although manganism has been observed in highly
exposed workers, the “weight of evidence to date is not sufﬁcient to
conclude that welders are at an increased risk of neurotoxicity from
exposure to Mn during the welding process.” Their review did not
acknowledge limitations in the reportedly negative studies of
Myers et al [46], Fryzek et al [75], and Fored et al [76], or point outthe evidence of positive effects in those studies; it did not examine
the central issue of Mn associations with non-PD parkinsonism.
Santamaria et al [49] misidentiﬁed some of the populations being
studied by Bowler et al [47]: these populations had no connection
with the bridge welders [27,36,67]. Although authors of the various
studies reporting positive ﬁndings discussed limitations in these
studies, the reviewers made no attempt to assess the likely impact
on inferences drawn. Santamaria et al [49] did not focus on the
subset of studies with adequate comparison populations and
reasonable exposure assessment. The medical signiﬁcance or
importance of subclinical ﬁndings was not addressed. These cri-
tiques do not rise to the level of serious challenge to the association
of parkinsonism with Mn exposures currently present in speciﬁc
industries.
6. Signiﬁcance of Mn-attributable deﬁcits
The history of Pb exposure is illuminating. Initial concerns
focused on severe Pb poisoning resulting from high Pb exposure
levels, whereas current concerns are for chronic low-level effects
and multiple endpoints [92]. Pb is now widely recognized as both
an environmental and occupational hazard requiring detailed
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exposure levels continue to decline. [93,94] Progress in under-
standing the long-term Pb hazard has been driven by neuro-
behavioral outcomes, especially cognitive, and has been aided by
development of sensitive measures of past exposure. For example
X-ray ﬂuorescence (XRF) from bone (tibia) provides a superior
measure of cumulative Pb exposure over blood levels reﬂecting
more recent exposures. [95]
The approximatepotencyofMn relative to theneurotoxicmetals,
Pb and Hg, can be inferred from published studies. In an extensive
study of 543 former workers from a plant manufacturing tetraethyl
lead, average air concentrations were 62 mg/m3 Pb [96]. The mean
tibial lead current in 1990 was 14.4 mg/g and the tibial level esti-
mated for the date last exposed (“peak” level) was 23.7 mg/g [97].
Statistically signiﬁcant decrements in performance on a variety of
neurobehavioral tests were associated with tibial lead (current and
peak), such as for vocabulary, memory, ﬁnger-tapping, Purdue
pegboard, and the Stroop test.93 In a population-based sample from
Baltimore, MD, USA, where the current tibial lead level averaged
18.8 mg/g, persistent deﬁcits in eye-hand coordination, executive
functioning, and verbal memory and learning were associated with
tibial lead levels [98]. A Finnish population of chloralkali workers
with average mercury exposures of 25 mg/m3 was compared with
wood-processing workers [99]. Increased symptoms of sleep dis-
orders, fatigue, and confusion were reported by the chloralkali
workers and therewas a nonsigniﬁcant possible effect of shift work.
The chloralkali workers performed signiﬁcantly better on a test of
eye-hand coordination, suggesting that the comparison group may
not have been appropriate (e.g., possible musculoskeletal injury). A
group of 98 dentists in Singapore, estimated to have average Hg
exposures of 16.7 mg/m3, was compared to university staff with no
known Hg exposure. Statistically signiﬁcant performance deﬁcits
were associated with cumulative exposure for 15 of 24 tests
including ﬁnger tapping, symbol-digit, digit span, visual recall, and
logical memory [100]. When compared to workers from an em-
broidery plant, 88ﬂuorescent lampmanufacturingworkers in China
with an average mercury exposure of 33 mg/m3 had signiﬁcantly
worse performance on ﬁnger tapping, mental arithmetic, two-digit
searches, switching attention, and visual reaction time. [101] Thus,
the neurobehavioral effects observed in working populations at air
concentrations of perhaps 60 mg/m3 Pb or 17e33 mg/m3 Hg are
roughly comparable to effects reported in Mn populations exposed
in the range of 50e500 mg/m3 Mn (Table 1).
A direct comparison of ﬁndings from studies of different
neurotoxic metals is difﬁcult because: (1) the sets of neuro-
behavioral tests used vary widely, (2) details on test scoring are not
always provided, and (3) exposure history is often poorly described.
In the case of Pb, outcomes are commonly presented as z-scores, not
actual test means, and biomarkers of exposure based on bone or
blood are often used as predictors rather than environmental levels;
however, some published studies provide an estimate of average
cumulative blood Pb concentration. Diverse test results can be
crudely compared by calculating a fractional change in score per
mg/m3-year of exposure (corresponding to 5 year at 0.2 mg/m3) or,
in the case of Pb, per 250 mg/dL-yr (corresponding to 5 year at 50 mg/
dL Pb in blood). Fractional change, here, is deﬁned as the difference
inmean score comparing an exposed and unexposed group, divided
by the unexposed group mean and by the average cumulative
exposure for the exposed group. The distributions of fractional
scores across neurobehavioral outcomes do not markedly differ
among Hg, Pb, and Mn; fractional scores for the three metals are
within a factor of 10 (Table 3) [23,26,28,30,31,33,81,87,88,97,99e
105]. For all threemetals, another source of variability in this table is
the source or form of the exposure. In the case of Mn, both welding
and electric furnaces are contributing. For Hg and Pb, both organicand inorganic forms are analyzed. This comparison assumes a linear
exposure response that is particularly suspect for a substance such
as Mn under homeostatic regulation.
Based on published work, including the 28 studies reporting
neurobehavioral effects associated with exposure, Mn should be
included in the group of substances including Pb, organic and
inorganic Hg, and solvent mixtures associated with consistent
patterns of neurobehavioral effects [10,12,106]. Alessio et al [106]
reviewed the neurobehavioral effects of long-term exposure to
low-level Mn, Pb, and Hg, recommending precautionary measures
to prevent more severe health effects in the population. Martin
[107] concluded that further investigation is needed but current
neuropsychological and clinical evidence justiﬁes preventive action
to reduce the adverse effects of Mn exposure.
Support for this conclusion is not universal. This may in part
reﬂect the dichotomy between the conﬂicting demands of indi-
vidual clinical evaluation and public health population-inference
and prevention. Clinical decision-making is typically based on a
single individual (worker) with little or no knowledge of coworker
status. Population studies have the beneﬁt of potentially detailed
simultaneous assessment of multiple risk factors, including expo-
sure history, and sensitive testing procedures. Important deﬁcits
that are readily discernible at the population level disappear into
the fog of normal variability at the individual level.
7. Discussion
The available weight of evidence supports the following
conclusions:
(1) Neurobehavioral changes, such as performance decrements on
standardized neuropsychological tests and adverse symptoms,
have been consistently reported in studies of welders and other
workers with known or likely sustained exposures to respirable
Mn. Workers with these Mn exposures are at risk for devel-
oping neurological effects.
(2) These effects are consistent with signs of early manganism.
(3) Although some research has suggested that Mn exposures
confer increased risk of PD (which might include accelerated
onset or detection), and may perturb dopamine metabolism,
this has not yet been established.
(4) Statistically signiﬁcant adverse neurobehavioral effects have
been reported at airborne concentrations below 0.2 mg/m3Mn.
[24,26e28,31,33]
The development of regulations to limit Mn exposures for
neurobehavioral effects would coordinate well with other regula-
tory health objectives. For example, in stainless steel welding,
which typically entails Mn exposures, hexavalent chromium ex-
posures also need to be controlled (for lung cancer risk), and in
most welding there are often surface coatings or contaminants that
are pyrolyzed and aerosolized with anticipated adverse effects.
Nitrogen oxides and ozone, causing welding-associated respiratory
effects, would also be controlled with engineered solutions to
control Mn exposure.
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